Date: Friday, April 24, 2026 Time: 5:00 PM to 6:30 PM
Advances in Cell-Specific Targeting Strategies for the Treatment of Osteoarthritis
BIG2-Dependent Dual Inhibition Of Tnfα And IL-1β Signaling Mitigates Osteoarthritis In Mouse And Primate Models - Wenyu Fu
Choline As A Food-Derived Metabolite Linking Synovitis To Osteoarthritis Progression - Rocío Paz González
Levi-04, A Novel Neurotrophin-3 Inhibitor, Demonstrates Clinically Meaningful Improvements In Pain And Physical Function Across A Range Of Oa Outcomes, Including The Omeract-Oarsi Responder Criteria - Claire Herholdt
Novel Micrornas As Biomarkers And Therapeutics For Early-Stage Knee Osteoarthritis - Madhu Baghel
Post Traumatic Osteoarthritis Development And Patient-Reported Outcomes In Young Adults Treated With Early Surgery Or Exercise Therapy For A Meniscal Tear: 7-Year Follow-Up Of The Dream Trial - Jonas Thorlund
Synovial Fluid Promotes An Anti-Inflammatory Macrophage Phenotype In Osteoarthritis - Franziska Winter
Therapeutic Efficacy Of Siabat Nanoparticle Intra-Articular Injection In Mitigating Osteoarthritis Pain: Evidence From Knee And Dorsal Root Ganglion Analyses In Mice - Chengchong Ai
Vagus Nerve Stimulation Suppresses Synovial Inflammation And Slows Osteoarthritis Progression In Acl-Ruptured Mice - Shivmurat Yadav
Venom-Derived Peptide E8 From Lonomia Obliqua Modulates Nf-Κb Signaling, Extracellular Matrix Remodeling And Cytoprotective Responses In Il-1β–Inflamed Articular Chondrocytes: A Proteomic Analysis - Amanda Teixeira De Melo
